- Poster presentation
- Open Access
PReS-FINAL-2225: Oxidative stress in children with episodic fever of unknown origin
© Vojinovic et al.; licensee BioMed Central Ltd. 2013
Published: 5 December 2013
Fever of unknown origin (FOU) i.e.: (1) a temperature greater than 38.3°C on several occasions, (2) more than 3 weeks' duration of illness, and (3) failure to reach a diagnosis despite 1 week of inpatient investigation are commonly seen in pediatric practice. The conditions could be caused by mutations of genes coding inflammasome sequences. In these instances activated neutrophils and monocytes intensively generate reactive oxidative species.
Aim of this study was to evaluate if there are oxidative changes of lipids in plasma and erythrocytes and advanced oxidation protein products (AOPP) in children with episodic FUO.
The study enrolled 25 children with episodic FUO (in afebrile phase) and 25 healthy age matched controls. Lipid peroxidation was evaluated measuring malondialdehyide (MDA) production by thiobarbituric-acid-reactive substances (TBARS) assay in plasma and erythrocytes while advanced oxidation protein products in plasma (AOPP) was measured in plasma using spectrophotometric methods to determinate TBARS and AOPP levels.
Mean duration of episodic fevers was 3.96 ± 2.8 years. Levels of erythrocytes MDA were higher in patients than in controls (86.26 ± 10.75 vs. 78.0 ± 3.21 nmol/g Hgb), however not significantly. There was no difference in MDA concentrations in plasma (2.42 ± 0.35 vs. 2.41 ± 0.39 μmol/L). Interestingly, levels of AOPP were significantly lower in patient group than in controls (18.8 ± 5.04 vs. 25.1 ± 3.35 μmol/L, p < 0.05).
The results confirm that erythrocyte membrane is the most vulnerable to the oxidative stress. However, duration of episodic fevers for approximately 4 years is not sufficient to cause significant oxidative modifications of lipids and proteins. Unexpected results for AOPP could be explained through the higher anti-oxidative capacity of blood.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.